SI-BONE, Inc.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Net loss ($17.5m) ($38.4m) ($43.7m) ($56.6m) ($61.3m) ($43.3m) ($30.9m) ($18.9m)
Depreciation and amortization $722k $774k $1.1m $2.1m $3.5m $5.4m $4.4m $5.8m $6.4m
Amortization of discount and premium on marketable securities ($209k) ($1.4m) $115k $1.3m $229k ($4.0m) ($5.4m) ($3.1m)
Amortization of debt issuance costs $259k $259k $292k $288k $198k $208k $153k $117k
Stock-based compensation $2.3m $7.5m $11.9m $16.9m $23.1m $24.1m $25.9m $25.5m $24.2m
Accounts receivable credit losses $0 $234k $14k $150k $761k $470k $570k ($7.1m)
Accounts receivable ($1.0m) ($3.2m) ($2.2m) ($569k) ($6.5m) ($2.1m) ($5.8m) ($3.0m) ($7.1m)
Inventory reserve $319k $1.7m $1.3m $2.0m
Inventory ($759k) ($2.1m) ($274k) ($5.8m) ($5.7m) ($4.7m) ($8.0m) ($8.7m) ($5.2m)
Accounts payable $251k $383k $835k ($532k) $2.5m ($1.1m) $1.9m ($1.8m) ($118k)
Accrued liabilities and other $1.3m $5.0m ($766k) $1.7m $1.2m $3.9m $1.9m $179k ($757k)
Prepaid expenses and other assets ($752k) ($515k) ($136k) ($594k) $810k ($762k) ($2k) ($1.0m)
Net cash used in operating activities ($14.5m)
($31.6m) -117.83%
($30.7m) +3.05%
($39.5m) -28.93%
($41.7m) -5.37%
($18.7m) +55.08%
($12.4m) +33.60%
($675k) +94.57%
$2.5m +467.11%
Loss on disposal of property and equipment $52k $171k $376k $399k $153k $1.3m $1.9m $1.6m
Purchases of property and equipment ($942k) ($2.4m) ($2.6m) ($6.4m) ($9.5m) ($7.8m) ($10.5m) ($8.4m) ($6.9m)
Unpaid purchases of property and equipment $82k $375k $26k $509k $1.1m $501k $588k $495k
Maturities of marketable securities $0 $159.8m $104.7m $160.0m $126.2m $137.5m $228.5m $205.1m
Purchases of marketable securities ($96.9m) ($143.9m) ($179.2m) ($102.0m) ($119.5m) ($189.5m) ($205.4m) ($192.5m)
Net cash provided by (used in) investing activities ($97.8m) $13.5m ($62.9m) $51.6m ($2.8m) ($59.8m) $12.6m $4.2m ($6.0m)
Proceeds from debt financing, net of debt issuance cost $0 $45.3m $35.0m $0 $36.0m $36.0m $0
Repayments of debt financing $0 ($45.3m) ($41.0m) $0 ($35.3m) ($36.0m) $0 $0
Final payment fee related to debt $0 $0 ($720k) $0
Proceeds from the exercise of common stock options $1.6m $1.5m $1.5m $2.6m $379k $4.4m $570k $1.2m
Proceeds from issuance of common stock under employee stock purchase plan $0 $2.2m $1.9m $2.3m $1.8m $2.2m $2.2m $2.2m $0
Net cash provided by financing activities $115.2m
$3.5m -96.97%
$136.4m +3810.58%
($1.7m) -101.25%
$2.2m +228.40%
$90.9m +4038.96%
$2.0m -97.85%
$3.4m +72.42%
$2.7m -19.96%
Effect of exchange rate changes on cash and cash equivalents ($94k) ($37k) $323k ($498k) ($429k) $132k ($479k) $431k ($233k)
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs $0 $134.6m $0 $0 $83.7m $0 $0
Net increase in cash and cash equivalents $2.7m ($14.7m) $43.1m $9.8m ($42.7m) $12.6m $1.7m $7.3m
Beginning of year $25.1m $10.4m $53.6m $63.4m $20.7m $33.3m $34.9m $42.2m
Cash paid for interest $5.5m $4.9m $4.3m $3.2m $2.6m $3.3m $3.3m $2.5m
Operating lease right-of-use assets obtained in exchange for operating lease liabilities $127k $143k $449k $251k